JP Stock MarketDetailed Quotes

4575 CanBas

Watchlist
  • 822
  • -66-7.43%
20min DelayTrading Dec 26 10:21 JST
15.71BMarket Cap-12.11P/E (Static)

About CanBas Company

CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.

Company Profile

Symbol4575
Company NameCanBas
Founded2000-01-18
MarketTSE Growth
Fiscal Year Ends06-30
Address9 Toriyoko-cho
Zip Code410-0801
Phone055-954-3666
Websitewww.canbas.co.jp

Company Executives

  • Name
  • Position
  • Salary
  • Makoto Katozumi
  • Chief Financial Officer and Head of Corporate Planning
  • --
  • Kazuyoshi Sakamoto
  • Director and Manager of Administration
  • --
  • Takumi Kawabe
  • Representative Director and President
  • --
  • Yasuyuki Komiyama
  • Independent Director
  • --
  • Toshio Furuta
  • Independent Director
  • --
  • Akira Shirakawa
  • Independent Director
  • --
Heat List
JP
Overall
Symbol
Price
% Chg

No Data